Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $86
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald maintains a Buy rating on Encompass Health (NYSE:EHC) and raises the price target from $82 to $86.
February 09, 2024 | 9:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities analyst David Macdonald maintains a Buy rating on Encompass Health and raises the price target from $82 to $86.
The increase in the price target by Truist Securities reflects a positive outlook on Encompass Health's stock, likely due to expected performance improvements or market conditions. This analyst endorsement can positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100